Evidence map›Paper›PMID 36357539›Full record

ArticleScientific reports2022

The antipsychotic drug sulpiride in the ventral pallidum paradoxically impairs learning and induces place preference.

Daniella Dusa, Tamás Ollmann, Veronika Kállai, László Lénárd, Erika Kertes, Beáta Berta, Ádám Szabó, Kristóf László, Rita Gálosi, Olga Zagoracz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Daniella DusaLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Tamás OllmannLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Veronika KállaiLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
László LénárdInstitute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602, Hungary.
Erika KertesLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Beáta BertaLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Ádám SzabóLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Kristóf LászlóNeuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Rita GálosiInstitute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602, Hungary.
Olga ZagoraczNeuropeptides, Cognition, Animal Models of Neuropsychiatric Disorders Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary.
Zoltán KarádiInstitute of Physiology, Medical School, University of Pécs, Szigeti Str. 12, P.O. Box: 99, Pécs, 7602, Hungary.
László PéczelyLearning in Biological and Artificial Systems Research Group, Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary. laszlo.peczely@aok.pte.hu.
University of Pecs · HU

Funding

New National Excellence Program of the Ministry for Innovation and Technology ÚNKP-17-4-I-PTE-144New National Excellence Program of the Ministry for Innovation and Technology ÚNKP-18-3-III-PTE-374New National Excellence Program of the Ministry for Innovation and Technology ÚNKP-21-5-PTE-1333University of Pecs, Medical School, Pecs, Hungary PTE ÁOK KA-2020-06
6 · The paper itself

Abstract

Sulpiride, as a D2-like dopamine (DA) receptor (D2R) antagonist, is an important antipsychotic drug in the treatment of schizophrenia. Recently, we have shown that the activation of D2Rs in the ventral pallidum (VP) modulates the activity of the ventral tegmental area (VTA) DAergic neurons. According to our hypothesis, intra-VP sulpiride can influence the motivational and learning processes, pervasively modifying the behavior of examined animals. In the present study, sulpiride was microinjected into the VP of male Wistar rats in three different doses. Morris water maze (MWM) test was applied to investigate the effects of sulpiride on spatial learning, while conditioned place preference (CPP) test was used to examine the potential rewarding effect of the drug. In order to show, whether the animals can associate the rewarding effect with an area which can be recognized only on its spatial location, we introduced a modified version of the CPP paradigm, the spatial CPP test. Our results show that the intra-VP sulpiride dose-dependently impairs learning processes. However, the largest dose of sulpiride induces place preference. Results of the spatial CPP paradigm demonstrate that the animals cannot associate the rewarding effect of the drug with the conditioning area based on its spatial location. In the CPP paradigm, locomotor activity decrease could be observed in the sulpiride-treated rats, likely because of a faster habituation with the conditioning environment. In summary, we can conclude that intra-VP sulpiride has a dual effect: it diminishes the hippocampus-dependent spatial learning processes, in addition, it has a dose-dependent rewarding effect.

Indexed as

Antipsychotic AgentsBasal ForebrainAnimalsMaleMorphineRatsRats, WistarReceptors, Dopamine D2SulpirideVentral Tegmental AreaAntipsychotic AgentsMorphineReceptors, Dopamine D2Sulpiride

Identifiers

PMID36357539
PMCPMC9649625
OpenAlexW4309077891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.